Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
AJ Bircher, T Harr, L Hohenstein, DA Tsakiris - Allergy, 2006 - Wiley Online Library
Anticoagulants, including heparins, coumarins, hirudins, and some of the previously used
plasma volume expanders, belong to the most widely used drugs. Hypersensitivity reactions …
plasma volume expanders, belong to the most widely used drugs. Hypersensitivity reactions …
[HTML][HTML] β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
…, KP McHugh, DA Tsakiris… - The Journal of …, 1999 - Am Soc Clin Investig
β3 integrins have been implicated in a wide variety of functions, including platelet aggregation
and thrombosis (αIIbβ3) and implantation, placentation, angiogenesis, bone remodeling, …
and thrombosis (αIIbβ3) and implantation, placentation, angiogenesis, bone remodeling, …
[HTML][HTML] Thrombophilia screening revisited: an issue of personalized medicine
G Colucci, DA Tsakiris - Journal of thrombosis and thrombolysis, 2020 - Springer
Clinical thrombophilia is the consequence of multiple gene and/or environment interactions.
Thrombophilia screening requires a targeted patient with specific indication, in which a …
Thrombophilia screening requires a targeted patient with specific indication, in which a …
Hemostasis in the mouse (Mus musculus): a review
DA Tsakiris, L Scudder… - Thrombosis and …, 1999 - thieme-connect.com
The common laboratory mouse (Mus musculus, Mus domesticus), the rat and the hamster are
members of the animal order of rodentia. Rodentia are estimated to have first appeared on …
members of the animal order of rodentia. Rodentia are estimated to have first appeared on …
Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease
BC Biedermann, S Sahner, M Gregor, DA Tsakiris… - The Lancet, 2002 - thelancet.com
… D Tsakiris measured vWF concentrations. C Jeanneret was involved in the morphometric …
M Gregor, D Tsakiris, and A Gratwohl were responsible for patient management and clinical …
M Gregor, D Tsakiris, and A Gratwohl were responsible for patient management and clinical …
Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1
K Wolf, DA Tsakiris, R Weber, P Erb… - The Journal of …, 2002 - academic.oup.com
We investigated the effect of antiretroviral therapy on vascular activation in 41 human
immunodeficiency (HIV)—infected patients receiving a regimen that included either at least 1 …
immunodeficiency (HIV)—infected patients receiving a regimen that included either at least 1 …
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation
…, S Meyer-Monard, D Heim, DA Tsakiris… - Blood, The Journal …, 2007 - ashpublications.org
We assessed incidence and risk factors of cardiovascular events in 265 patients undergoing
allogeneic hematopoietic stem-cell transplantation (HSCT) between 1980 and 2000 and …
allogeneic hematopoietic stem-cell transplantation (HSCT) between 1980 and 2000 and …
Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
B Müller, DA Tsakiris, CB Roth… - European journal of …, 2001 - Wiley Online Library
The influence of thyroid failure on haemostasis is controversial, both hypocoagulable and
hypercoagulable states have been reported. Since both subclinical and overt hypothyroidism …
hypercoagulable states have been reported. Since both subclinical and overt hypothyroidism …
Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories
…, G Reber, B Seifert, H Stricker, DA Tsakiris… - Thrombosis research, 2012 - Elsevier
INTRODUCTION: Rivaroxaban (RXA) is licensed for prophylaxis of venous thromboembolism
after major orthopaedic surgery of the lower limbs. Currently, no test to quantify RXA in …
after major orthopaedic surgery of the lower limbs. Currently, no test to quantify RXA in …
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
We studied occurrence, risk factors and outcome of patients with transplant-associated
microangiopathy (TAM) after allogeneic stem cell transplantation (HSCT). A total of 221 …
microangiopathy (TAM) after allogeneic stem cell transplantation (HSCT). A total of 221 …